Publicacións en colaboración con investigadores/as de Vall d'Hebron Institut de Recerca (20)

2024

  1. EASL International Recognition Award Recipient 2024: Prof. Norah Terrault

    Journal of Hepatology

  2. Frailty and sarcopenia in patients with acute-on-chronic liver failure: Assessment and risk in the liver transplant setting

    Annals of Hepatology, Vol. 29, Núm. 5

  3. Hyponatremia after COVID-19 is frequent in the first year and increases re-admissions

    Scientific Reports, Vol. 14, Núm. 1

  4. Long-term outcomes (beyond 5 years) of liver transplant recipients-A transatlantic multicenter study

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 30, Núm. 2, pp. 170-181

  5. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors

    Journal of Hepatology, Vol. 80, Núm. 6, pp. 904-912

2023

  1. Proceedings of the 27th Annual Congress of the International Liver Transplantation Society

    Transplantation

2022

  1. Proceedings of the 26th Annual Virtual Congress of the International Liver Transplantation Society

    Transplantation, Vol. 106, Núm. 9, pp. 1738-1744

  2. Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients

    American Journal of Transplantation

  3. Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study

    Diagnostics, Vol. 12, Núm. 7

  4. Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy

    Annals of Hepatology, Vol. 27, Núm. 3

  5. What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations

    Clinical Transplantation, Vol. 36, Núm. 10

2021

  1. A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement

    Journal of Hepatology, Vol. 75, Núm. 2, pp. 275-283

  2. Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort

    Transplant International, Vol. 34, Núm. 10, pp. 1908-1913

  3. The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19

    Therapeutic Advances in Gastroenterology, Vol. 14

2020

  1. Does retraction after misconduct have an impact on citations? A pre-post study

    BMJ Global Health, Vol. 5, Núm. 11

  2. Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States

    Transplantation, Vol. 104, Núm. 10, pp. 2078-2086

2017

  1. Sofosbuvir and daclatasvir in mono-and HIV-coinfected patients with recurrent hepatitis C After liver transplant

    Annals of Hepatology, Vol. 16, Núm. 1, pp. 86-93

2014

  1. Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1

    Journal of Viral Hepatitis, Vol. 21, Núm. 10, pp. e118-e128

  2. Outcome of early vs. Deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients

    Annals of Hepatology, Vol. 13, Núm. 2, pp. 219-230

2012

  1. Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature

    Liver Transplantation, Vol. 18, Núm. 2, pp. 201-205